Published on 4/17/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Lehman prices $100.4 million 7.5% Yeelds linked to Boston Scientific
New York, April 17 - Lehman Brothers Holdings Inc. priced $100.412 million of 7.5% Yeelds (Yield Enhanced Equity-Linked Debt Securities) due April 28, 2007 linked to Boston Scientific Corp. stock, according to a 424B5 filing with the Securities and Exchange Commission.
| Issuer: | Lehman Brothers Holdings Inc.
|
| Issue: | Yeelds (Yield Enhanced Equity-Linked Debt Securities) medium-term senior series H notes
|
| Underlying stock: | Boston Scientific Corp.
|
| Amount: | $100,412,100
|
| Greenshoe: | $15,618,150
|
| Maturity: | April 28, 2007
|
| Coupon: | 7.5%, payable quarterly
|
| Price: | Par of $21.594
|
| Payout at maturity: | Final value of Boston Scientific stock on valuation date of April 23, 2007, capped at $25.377, payable in stock or cash at Lehmans's option
|
| Cap price: | $25.377, 117.52% of initial value
|
| Pricing date: | April 13
|
| Settlement date: | April 21
|
| Underwriter: | Lehman Brothers Inc.
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
